PFIZER INC — Director's Dealing 2021

Mar 1, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2021-02-25

Reporting Person: Fonseca Lidia (Executive Vice President)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-25	Stock Appreciation Rights	$33.8200	A	56888.0000	Acquired	2026-02-25	Common Stock (56888.0000)	Direct
2021-02-25	Stock Appreciation Rights	$33.8200	A	49153.0000	Acquired	2028-02-25	Common Stock (49153.0000)	Direct

Footnotes

F1: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.

F2: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.